The winds of political change have hit the healthcare industry, with drug makers seemingly taking the brunt of the gale. Industry-leading companies like Pfizer (NYSE: PFE), Merck (NYSE: MRK), and Bristol Myers Squibb (NYSE: BMY) have seen their stocks fall and their yields rise.The pharmaceutical niche is an attractive place for contrarian investors to start looking for stocks to buy. If you have $1,000, here's one pharma stock that seems to stand out from the pack.Image source: Getty Images.Continue reading
Finance
September 24, 2025
The Smartest Dividend Stock to Buy With $1,000 Right Now
Advertisement
Related Articles
TruAlt Bioenergy shares list at 11% premium over …
TruAlt Bioenergy share price: TruAlt Bioenergy shares debuted with a premium on October 3 after …
1 day, 21 hours ago
5